Scholars Central

Conference abstract

Chitosan-coated Solid Lipid Nanoparticles for the Oral Absorption Enhancement of Insulin

Authors: Bruno Sarmento

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Insulin has usually been administered subcutaneously in the treatment of diabetes mellitus. Oral delivery of insulin is expected to be an alternative route but has some limitations, including low HK,the luminal cavity, and poor permeability across intestinal epithelium because of its high molecular weight and lack of lipophilicity. Solid lipid nanoparticles (SLN) show several advantages as drug delivery systems, such as good tolerability, biodegradation, and the possibility of large industrial scale production. Enhancing mucoadhesion properties of nanoparticles, namely by using chitosan coating has been a successful strategy used to promote the contact of carriers with the intestinal epithelium, thus increasing the therapeutic proteins concentration at the site of absorption. In this presentation, it will be present the recent advances of our research group on the developing of a new nanoparticulate carrier intended for the oral insulin administration, composed of a lipid core aimed to protect and to control the release of insulin and coated by the mucoadhesive chitosan to improve insulin absorption. In vitro permeation experiments in Caco-2 and Caco-2/HT20 cell cultures demonstrated the ability of insulin to cross through the intestinal mucosa, mainly when encapsulated into chitosan-coated SLN. Insulin-loaded SLN decreased glycemia in diabetic animal model compared oral insulin solution, and the hypoglycemic effect was higher when SLN are further coated with chitosan. Chitosan coating was found to improve the stability and intestinal absorption properties of SLN containing insulin, which may contribute for the development of an optimized oral insulin formulation.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalPharmaceutica Analytica Acta
  • SubjectPharmaceutical Sciences
  • BylineArticles whose byline prints “Bruno Sarmento”